Prospective Study Of The Procedure-less Intra-gastric Elipse Balloon: Is It Effective & Safe?

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

April 30, 2017

Conditions
Obese
Interventions
DEVICE

intragastric Elipse Device

"Obesity prevalence is increasing worldwide, and Kuwait is currently considered to be the country with the most obese population1. Accordingly, standardization of the weight loss procedures has been made according to the Body Mass Index (BMI), keeping the more advanced surgeries for class II obesity (BMI 35- 39.9) and above, with consideration of other factors like, for example, obesity-related comorbidities. For those patients whom considered in the category of overweight (BMI = 25- 29.9) \& class I obesity (BMI 30- 34.9), after failure of diet attempts, the weight loss options are limited. Of the highly requested options are the various types of intra-gastric balloons. Conventional endoscopic gastric balloons have proven to be safe and effective, with Excess Weight Loss (%EWL) of 25-50%2. A new swallowable gastric balloon, named Elipse, has been launched recently in Kuwait and became highly popular due to its unique concept of being procedure-less."

All Listed Sponsors
lead

Amiri Hospital

OTHER_GOV

NCT03160469 - Prospective Study Of The Procedure-less Intra-gastric Elipse Balloon: Is It Effective & Safe? | Biotech Hunter | Biotech Hunter